Abstract

Topical corticosteroids are the mainstay of treatment for atopic dermatitis (AD) and when used as directed, are highly effective. Upwards of 50% to 88% of children and adolescents are non-adherent with their prescribed regimen. In addition, inaccurate dosing of topical steroids is a large source of treatment failure. Existing studies exploring the barriers and interventions in adherence place the blame and responsibility on patients and clinicians to improve outcomes. Little is known about topical drug delivery devices as a source of non-adherence, specifically issues concerning inaccurate dosing.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call